Hoshi Iryo-Sanki (7634) Q4 2025 earnings summary

Executive summary

• Revenue for the year ended March 2025 was ¥15,102 million, up 2.2% year-over-year, with operating profit at ¥1,982 million (+1.0%) and net profit attributable to shareholders at ¥1,463 million (+4.2%).

• The company maintained stable operations amid a gradually recovering domestic economy, focusing on reliable supply and safety in medical, nursing, and welfare sectors.

Financial highlights

• Gross profit was ¥7,563 million, with an operating margin of 13.1% and net margin of 8.2%.

• Total assets increased to ¥24,590 million, and equity rose to ¥18,715 million.

• Cash and equivalents at year-end were ¥5,925 million, down ¥3,834 million from the previous year.

• Dividend per share was maintained at ¥70, with a payout ratio of 14.9%.

Outlook and guidance

• For the year ending March 2026, revenue is forecast at ¥15,260 million (+1.0%), operating profit at ¥2,070 million (+4.4%), and net profit at ¥1,476 million (+0.9%).

• The company aims to strengthen digital transformation, invest in workplace improvements, and respond to rising demand in welfare and home healthcare.